I agree. Very good quarterly report.
DEP trials still very positive with likelihood of other partnerships.
Negatives are the FDA debacle. Cant see how they claim progress there. first knock back 2012.
18 months since the latest FDA rejection with still no decent explanation of why it was knocked back. Progress it is not.
Undisclosed partnerships seem to have disappeared.
Overall a good report. Just hope in house DEP trials not delayed too much.
I agree. Very good quarterly report.DEP trials still very...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.90M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |